Poststreptococcal reactive arthritis: what is it and how do we know?
- PMID: 15150434
- DOI: 10.1093/rheumatology/keh225
Poststreptococcal reactive arthritis: what is it and how do we know?
Abstract
Objective: To find out whether poststreptococcal reactive arthritis (PSRA) is a discrete, homogeneous clinical syndrome.
Method: Literature review from case reports and case series.
Results: One hundred and eighty-eight cases were identified. The age distribution was bimodal, with one peak in childhood and one peak in adulthood. Eighty-three percent of streptococcal isolates were group A. The clinical presentation was heterogeneous but appeared different both from that of acute rheumatic fever (ARF) and from that of HLA B27-associated reactive arthritis. Carditis was rare.
Conclusions: The term PSRA encompasses significant heterogeneity. The link between the arthritis and the streptococcal infection is unproven.
Comment in
-
Poststreptococcal reactive arthritis (PSRA): a plea for diagnostic criteria.Rheumatology (Oxford). 2005 Jan;44(1):136; author reply 136-7. doi: 10.1093/rheumatology/keh433. Rheumatology (Oxford). 2005. PMID: 15611313 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
